First-line mCapOX+Cetuximab vs. mFOLFOX6+Cetuximab for Metastatic Left-sided CRC With Wild-type RAS/BRAF Genes

Clinical trial NCT05022030 · UNKNOWN

Trial details

NCT number: NCT05022030
Sponsor: West China Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Colo-rectal Cancer Capecitabine Cetuximab

Start date: 2021-07-21
Primary completion: 2025-06-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.